E
ELAN
HealthcareElanco
Price Chart
Loading...
Market Data
Revenue TTMXBRL
—
Net IncomeXBRL
—
Gross MarginXBRL
—
EPS (Diluted)XBRL
—
No analysis generated yet. Run the pipeline for this company.
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
7
GuidanceBullishPer-CompanyMar 18, 2026
Elanco shares surge 7.6% on Q4 performance and constructive 2026 revenue and EBITDA guidance
- ▸ELAN shares rose 7.6% to close at $25.18 on high trading volume
- ▸Management issued constructive 2026 guidance targeting revenue growth and EBITDA expansion
- ▸Upcoming quarterly revenue expected at $1.28B, up 7.7% year-over-year
- ▸Upcoming quarterly EPS expected at $0.35, down 5.4% year-over-year
- ▸Consensus EPS estimate for upcoming quarter revised 1.8% lower over last 30 days